Cours PixarBio Corporation Other OTC
Actions
PXRB
US72582G1094
Produits pharmaceutiques
CA 2014 | - | CA 2015 | - | Capitalisation | 81 73,6 |
---|---|---|---|---|---|
Résultat net 2014 | -2 M -1,82 M | Résultat net 2015 | -5 M -4,54 M | VE / CA 2014 * | - |
Trésorerie nette 2014 * | - 0 | Trésorerie nette 2015 * | - 0 | VE / CA 2015 * | - |
PER 2014 * |
-
| PER 2015 * |
-
| Employés | - |
Rendement 2014 * |
-
| Rendement 2015 * |
-
| Flottant | 24,87% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Francis Reynolds
CEO | Chief Executive Officer | 61 | 04/08/14 |
Ken Stromsland
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paul Dawidczyk
PRN | Corporate Officer/Principal | - | - |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Francis Reynolds
CEO | Chief Executive Officer | 61 | 04/08/14 |
David Cass
BRD | Director/Board Member | - | 01/06/14 |
Bernard Ho
BRD | Director/Board Member | - | 22/12/17 |
Varia. 1 janv. | Capi. | |
---|---|---|
+21,63% | 44,11 Md | |
+23,03% | 22,71 Md | |
+18,22% | 15,15 Md | |
+12,66% | 13,56 Md | |
+60,18% | 12,7 Md | |
-10,02% | 6,84 Md | |
-0,05% | 6,79 Md | |
-8,87% | 5,73 Md | |
+12,92% | 5,63 Md |